Why a potential $7.4 billion Purdue Pharma opioid settlement frustrates some victims
Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...
Purdue Pharma submits opioid lawsuit settlement plan, including up to $7 billion cash from Sacklers
Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...
Fierce Pharma2d
Purdue Pharma files new $7.4B bankruptcy reorganization plan to settle opioid claims
After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a ...
BioSpace1d
Purdue Files for Bankruptcy Anew to Support $7.4B+ Opioid Settlement
The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the ...
Claimant says opioid victims won't get justice in proposed Purdue settlement
Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.
Hosted on MSN1mon
Purdue Pharma’s Sacklers Agree to New $6.5 Billion Deal for Opioid Lawsuits
Purdue Pharma’s owners from the Sackler family ... of dollars in profit distributions from the company after its guilty plea to federal criminal charges in 2007 and that all the dividend ...
THE WEEK1y
The next Supreme Court case could spell the end of Purdue Pharma
The U.S. Supreme Court is hearing many important cases this term, but perhaps none are as consequential — or controversial — as one involving Purdue Pharma. The long-maligned pharmaceutical ...